
Startups & growth Analysis
Editpep develops a nonviral way to deliver CRISPR for brain therapies
Editpep is developing a nonviral way to deliver CRISPR machinery, with brain therapies as its first focus and licensing as a possible commercial route.

Dana Foss is CEO and a co-founder of Editpep. She is a co-inventor of its PERC delivery technology.
Loading profile details…
Loading recent changes…
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Profile reviewed . Values carry their own dates.